Understanding Mutational Drivers of Risk: An Important Step Toward Personalized Care for Patients with Renal Cell Carcinoma

Shreyas Joshi; Alexander Kutikov

doi:10.1016/j.euf.2016.07.008

Understanding Mutational Drivers of Risk: An Important Step Toward Personalized Care for Patients with Renal Cell Carcinoma

Shreyas Joshi, Alexander Kutikov

Temple University

Research output: Contribution to journal › Editorial

2 Scopus citations

Abstract

The identification of clinically relevant genetic mutations in renal cell carcinoma is an important step on the path toward personalized management of this disease.

Original language	English
Pages (from-to)	428-429
Number of pages	2
Journal	European Urology Focus
Volume	3
Issue number	4-5
DOIs	https://doi.org/10.1016/j.euf.2016.07.008
State	Published - Oct 2017

Keywords

Biomarkers, Tumor
Carcinoma
Carcinoma, Renal Cell
DNA Mutational Analysis
Genetic Predisposition to Disease
Humans
Kidney Neoplasms
Molecular Targeted Therapy
Mutation
Precision Medicine
Risk

Access to Document

10.1016/j.euf.2016.07.008

Cite this

@article{d5f6d6b2a7b3488f8ad781ae297ef083,

title = "Understanding Mutational Drivers of Risk: An Important Step Toward Personalized Care for Patients with Renal Cell Carcinoma",

abstract = "The identification of clinically relevant genetic mutations in renal cell carcinoma is an important step on the path toward personalized management of this disease.",

keywords = "Biomarkers, Tumor, Carcinoma, Carcinoma, Renal Cell, DNA Mutational Analysis, Genetic Predisposition to Disease, Humans, Kidney Neoplasms, Molecular Targeted Therapy, Mutation, Precision Medicine, Risk",

author = "Shreyas Joshi and Alexander Kutikov",

year = "2017",

month = oct,

doi = "10.1016/j.euf.2016.07.008",

language = "English",

volume = "3",

pages = "428--429",

journal = "European Urology Focus",

issn = "2405-4569",

publisher = "Elsevier BV",

number = "4-5",

}

TY - JOUR

T1 - Understanding Mutational Drivers of Risk

T2 - An Important Step Toward Personalized Care for Patients with Renal Cell Carcinoma

AU - Joshi, Shreyas

AU - Kutikov, Alexander

PY - 2017/10

Y1 - 2017/10

N2 - The identification of clinically relevant genetic mutations in renal cell carcinoma is an important step on the path toward personalized management of this disease.

AB - The identification of clinically relevant genetic mutations in renal cell carcinoma is an important step on the path toward personalized management of this disease.

KW - Biomarkers, Tumor

KW - Carcinoma

KW - Carcinoma, Renal Cell

KW - DNA Mutational Analysis

KW - Genetic Predisposition to Disease

KW - Humans

KW - Kidney Neoplasms

KW - Molecular Targeted Therapy

KW - Mutation

KW - Precision Medicine

KW - Risk

UR - http://www.scopus.com/inward/record.url?scp=84997839876&partnerID=8YFLogxK

U2 - 10.1016/j.euf.2016.07.008

DO - 10.1016/j.euf.2016.07.008

M3 - Editorial

C2 - 28753782

AN - SCOPUS:84997839876

SN - 2405-4569

VL - 3

SP - 428

EP - 429

JO - European Urology Focus

JF - European Urology Focus

IS - 4-5

ER -

Understanding Mutational Drivers of Risk: An Important Step Toward Personalized Care for Patients with Renal Cell Carcinoma

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this